Activated Charcoal
Brand names: CharcoAid, Actidose-Aqua
Activated charcoal is an oral adsorbent that binds many ingested poisons within the gut to reduce their absorption, and is most effective when given soon after ingestion.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Its very large adsorptive surface area binds many drugs and toxins in the gastrointestinal lumen, reducing systemic absorption; repeated doses can also enhance elimination of some drugs by interrupting enterohepatic and enteroenteric recycling.
Prescribing in practice
- It requires a protected airway because of the aspiration risk — avoid in a drowsy or obtunded patient unless the airway is secured by intubation.
- It does not bind metals (such as iron or lithium), alcohols, corrosives or many solvents, so it is ineffective for these poisonings.
- Repeated doses are used for certain poisons; confirm indications and timing with Toxbase/NPIS.
Monitoring
Assess and monitor conscious level and airway protection before and after administration, watch for vomiting and signs of aspiration, and review bowel sounds, especially with repeated doses.
Counselling the patient
- Warn the team that charcoal is only useful early and that a safe, protected airway is a prerequisite.
- Note that it is ineffective against metals, alcohols and corrosives.
- Check Toxbase/NPIS for whether single or repeated doses are appropriate for the specific poison.
Evidence & guidelines
Standard gut decontamination option in selected poisonings (Toxbase/NPIS).
Reference: TOXBASE; NPIS guidelines; Position Paper on Single-Dose Activated Charcoal (AACT/EAPCCT); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
Activated Charcoal is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.